mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
QL-XII-61 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.02 |